Esuprone, formerly known as LU-43839, is a MAO-A inhibitor potentially for treatment of depression. References: Loscher W, Lehmann H, Teschendorf HJ, Traut M, Gross G. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy. J Pharmacol Exp Ther. 1999 Mar;288(3):984-92. PubMed PMID: 10027835.

纯度：≥98%

CAS：91406-11-0